Feng Xu

A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas

Mrinal M. Gounder, Todd M. Bauer, Gary K. Schwartz et al. · Journal of Clinical Oncology · 2023 · 83 citations · Full text

Hyaluronate- and gelatin-based hydrogels encapsulating doxycycline as a wound dressing for burn injury therapy

Yan Hu, Bangrui Yu, Yuanbo Jia et al. · Acta Biomaterialia · 2023 · 52 citations

Biopolymer Gel, Hydrogels, Engineering +11

Development and Validation of a Nomogram to Predict the Risk of Lumbar Disk Reherniation within 2 Years After Percutaneous Endoscopic Lumbar Discectomy

He Hang, Jun Ma, Chengjie Xiong et al. · World Neurosurgery · 2023 · 14 citations · Full text

Pediatric non-diabetic ketoacidosis: a case-series report

Ke Bai, Yueqiang Fu, Chengjun Liu et al. · BMC Pediatrics · 2017 · 11 citations · Full text

The Spectrum of Biopsy-Proven Kidney Diseases, Causes, and Renal Outcomes in Acute Kidney Injury Patients

Zulihumaer Abuduwupuer, Qunjuan Lei, Shaoshan Liang et al. · ˜The œNephron journals/Nephron journals · 2023 · 10 citations · Full text